Recall archive / FDA drug enforcement
Espumil, Lipophilic foam base, 500 ml, 24G15-T02-115604 — FDA record D-0138-2026
Reported ongoing
Status as reported in the agency record. FDA warns that enforcement status may not track the current recall lifecycle; check the current official notice.
Source date Sep 12, 2025. Retrieved Oct 1, 2026. Last updated Oct 1, 2026.
Archive changed Oct 1, 2026. USDA FSIS records are unavailable; check FSIS directly. Source coverage and dates.
What the record says
- Product
- Espumil, Lipophilic foam base, 500 ml, 24G15-T02-115604
- Reason
- Labeling: Not Elsewhere Classified
- Classification
- Class III
- Recalling firm
- Letco Medical LLC
- Quantity
- 173 500 ml bottles
- Agency-reported status
- Ongoing
- Source record identifier
- D-0138-2026
What the recall classes mean. Classification is an agency assessment, not individual medical advice.
Lot and product identifiers
| Label field | Details supplied by the agency |
|---|---|
| Lot, code or applicability | Batch # 24G15-T02-115604, exp. 11/30/2026 |
Match all identifying details in the current notice. A brand name alone is not enough.
Distribution
Product was distributed to: Letco Medical, LLC 1316 Commerce Drive Decatur, AL 35601 Product was further distributed to 44 compounding pharmacies and 2 distributors.
States below are derived from the distribution text, including nationwide wording. They are not inferred from the firm's address.
Dates in the source
- Report date
- Nov 5, 2025
- Recall initiation date
- Sep 12, 2025
- Center classification date
- Oct 29, 2025
FDA company pages use the listing date; enforcement records use initiation dates; CPSC uses recall date; NHTSA uses report-received date. These dates are not interchangeable.